MIT researchers are using nanotechnology to help doctors detect cancer in their patients sooner, increasing their odds of beating the disease. To diagnose cancer, doctors look for specific proteins secreted by cancer cells. The problem ...
Tags: MIT, nanotechnology, detect cancer, specific proteins
UCL has entered into a collaborating agreement with Eisai to identify, validate and develop new therapeutics for treating neurological diseases such as Alzheimer's, Parkinson's and other related disorders. The collaboration will also ...
Tags: neurological disease, collaboration, therapeutics, clinical trial
Navidea Biopharmaceuticals has entered into an agreement to license Alseres Pharmaceuticals' Iodine-123 radiolabeled imaging agent, [123I]-E-IACFT Injection (CFT). The patented small molecule radiopharmaceutical imaging agent, which ...
NorthShore University HealthSystem has used Amyvid (Florbetapir F 18 Injection) radioactive diagnostic agent to evaluate patients for Alzheimer's disease. The diagnostic agent, approved for positron emission tomography (PET) imaging ...
Tags: clinical trial, Alzheimer's disease, positron emission tomography
Scientists at Princeton University say they have used nanotechnology to make tests to detect diseases,such as cancer and Alzheimer's,3 million times more sensitive. That means what researchers are calling a breakthrough in nanotechnology ...
Tags: nanotechnology, detect diseases, Princeton University, D2PA, Cancer
Phil Shoesmith, head of IT for the Alzheimer's Society charity, has called on Salesforce to keep its promise to build a datacentre in the European Union (EU). The Alzheimer's Society helps 100,000 suffers of dementia in England, Wales and ...
Tags: Alzheimer, EU, Salesforce
IBA Molecular has entered into an agreement to manufacture and distribute Piramal's new diagnostic imaging agent, 18F-Florbetaben, in the US and Europe. 18F-Florbetaben, which is currently in development for use with positron emission ...
Tags: 18F-Florbetaben, clincical product, clinical technology
Cardinal Health has entered into an agreement to manufacture and distribute Eli Lilly and Company's new diagnostic imaging agent, Amyvid, at seven sites throughout the US. Amyvid, a radioactive diagnostic agent, tagged with a ...
Inscopix, a provider of in vivo cellular imaging solutions, and SRI International have entered into a collaboration agreement on neuroscience imaging R&D program. Under the agreement, SRI's Center for Neuroscience and Metabolic ...
Tags: company cooperation, clinical research, clinical technology
UK frozen food retailer Iceland Foods has reported a 14% increase in full-year profits as it reported a solid increase in sales despite fierce competition. Iceland booked net profit before tax of GBP147.5m (US$229.8m) for the 53 weeks to ...
Tags: UK, frozen food, Iceland Foods
The US Food and Drug Administration (FDA) has accepted Avanir Pharmaceuticals' investigational new drug (IND) application for the study of AVP-923, an investigational drug for the treatment of agitation in patients with Alzheimer's disease. ...
Tags: AVP-923, Alzheimer's disease, IND
Functional Neuromodulation has treated the first US patient with a deep brain stimulation(DBS)system in a randomized,double-blind,controlled trial. The trial,named Advance,has implanted the first patient at Johns Hopkins to demonstrate ...
Tags: Advance, DBS system, Functional Neuromodulation, trial
Neurotez has received US patent covering hormone Leptin for treating Alzheimer's disease (AD) resulting from accumulation of an amyloid peptide or for improving resilience of cognitive function by modulating the accumulation of the amyloid ...
Tags: Leptin, Alzheimer's disease, endogenous pluripotent hormone
Novartis has obtained the US Food and Drug Administration (FDA) approval for a new 13.3 mg/24 h dosage strength of its Exelon Patch (rivastigmine transdermal system), designed to treat patients with mild to moderate Alzheimer's disease. ...
Tags: Alzheimer's disease, Novartis Pharmaceuticals, Exelon Patch
Nestlé Health Science has purchased an undisclosed stake in Accera, a privately-held US-based company that is involved in the development and the commercialization of medical foods for neurodegenerative disorders such as Alzheimer's ...